Organogenesis INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCanton, MA
SAM.gov UEIVKK3WXM4RCZ7
Organogenesis makes Apligraf, an FDA-approved skin substitute containing bioactive living cells designed to close diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). The product is supported by randomized controlled trials demonstrating faster wound closure compared to standard treatment.
Summarized from the company’s own website
What they make
Cultured Human Cell Skin DressingDressing, Wound And Burn, InteractiveDressing, Wound, DrugMesh, SurgicalWound Dressing With Animal-Derived Material(S)
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Organogenesis INC | Canton | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.